L26/P-632 Comparison of an SNP-based targeted sequencing PGT-A approach with conventional whole-genome amplification PGT-A workflows
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E.P. Yang und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do SNP-based targeted sequencing PGT-A approaches differ from conventional PGT-A testing in embryo CNV, ploidy, and mosaic classification? Summary answer The SNP-based approach showed full concordance for euploid embryos, concordant detection of aneuploidy with chromosome-level differences, and substantial reclassification of mosaic embryos. What is known already Preimplantation genetic testing for aneuploidy (PGT-A) is widely used to support embryo selection in IVF; however, significant variability exists across analytical platforms and bioinformatic pipelines. Differences in amplification methods, sequencing resolution and interpretation thresholds may lead to inconsistent embryo classification, particularly for mosaicism. Mosaic embryos remain one of the most debated aspects of PGT-A due to variability in detection sensitivity and reporting criteria. In addition, conventional PGT-A approaches have limited capacity to assess uniparental disomy (UPD) and abnormal ploidy status, which may contribute to misclassification and unnecessary embryo discard. Study design, size, duration This retrospective validation study included 75 blastocyst-stage embryos analyzed in parallel using an SNP-based targeted sequencing PGT-A workflow and a conventional whole-genome (WGA) PGT-A workflow. Concordance between workflows was evaluated across euploid, aneuploid and mosaic classifications. Participants/materials, setting, methods Trophectoderm biopsies from embryos undergoing PGT-A were independently analyzed by two workflows with distinct methodological principles. The SNP-based approach utilized a proprietary pre-amplification strategy followed by targeted sequencing of approximately 9,800 SNP markers for copy-number analysis and ploidy assessment. The comparator workflow utilized conventional WGA followed by low-pass sequencing. Results were categorized as euploid, aneuploid or mosaic, and concordance was assessed descriptively. Main results and the role of chance Among the 75 embryos analyzed, euploid classification showed complete concordance between workflows (100%, 8/8). For aneuploid embryos, embryo-level concordance was 96% (52/54), with discordance confined to embryos previously reported as segmental or chaotic abnormalities and reclassified as euploid by the SNP-based approach. Segmental and chaotic abnormalities are known to exhibit lower concordance than whole-chromosome aneuploidies. At the chromosome level, aneuploid concordance was 33%, and no concordance was observed for mosaic classification (0%, 0/13). Of the embryos classified as mosaic by the conventional test, ten of thirteen (76.9%) were reclassified as euploid by SNP-based approach. The remaining three embryos (23.1%) showed discordant findings, where SNP-based approach identified mosaic or aneuploid abnormalities involving different chromosomes than those reported by the comparator. These discrepancies are consistent with differences in analytical resolution enabled by uniform pre-amplification and SNP-level confirmation. In addition, the SNP-based approach identified one triploid (outside the primary cohort) and one haploid/genome-wide UPD embryo, demonstrating the ability to detect abnormal ploidy states beyond standard aneuploid classification. The triploid embryo, previously identify as three-pronuclei (3PN) on morphology, was genetically confirmed by the SNP-based approach. In addition, family-based SNP analysis showed 100% concordance with expected cohort relationships, supporting sample identity verification and data integrity. Limitations, reasons for caution The study was limited by its retrospective design, modest sample size and lack of correlation with implantation or live-birth outcomes. Findings should therefore be interpreted as an analytical comparison rather than clinical efficacy. Wider implications of the findings These results highlight substantial workflow-dependent variability in mosaic and chromosome-level aneuploid classification. SNP-based targeted sequencing with uniform pre-amplification may support more refined interpretation of PGT-A results and expanded assessment of ploidy states. Trial registration number No
Zitieren
APA
Yang, E., Hsu, A., Lim, E., Soo, Y., Tee, S., Yeh, W., Hong, J., & Wang, T. (2026). L26/P-632 Comparison of an SNP-based targeted sequencing PGT-A approach with conventional whole-genome amplification PGT-A workflows. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.962
Vancouver
Yang E, Hsu A, Lim E, Soo Y, Tee S, Yeh W, et al. L26/P-632 Comparison of an SNP-based targeted sequencing PGT-A approach with conventional whole-genome amplification PGT-A workflows. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.962
BibTeX
@article{Yang2026,
author = {Yang, E.P. and Hsu, A. and Lim, E.L. and Soo, Y.C. and Tee, S.T. and Yeh, W.C. and Hong, J.J. and Wang, T.},
title = {L26/P-632 Comparison of an SNP-based targeted sequencing PGT-A approach with conventional whole-genome amplification PGT-A workflows},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.962}
}
EUVIMED